ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,000 | – | 1,800 | +592.3% | 0.00% | – |
| Q3 2016 | $0 | – | 260 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 260 | -74.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 1,000 | +609.2% | 0.00% | – |
| Q2 2015 | $1,000 | -93.3% | 141 | -94.4% | 0.00% | -100.0% |
| Q2 2014 | $15,000 | -80.8% | 2,500 | -79.8% | 0.00% | -66.7% |
| Q1 2014 | $78,000 | +1014.3% | 12,400 | +933.3% | 0.01% | +500.0% |
| Q4 2013 | $7,000 | +40.0% | 1,200 | +20.0% | 0.00% | 0.0% |
| Q3 2013 | $5,000 | -37.5% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2013 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |